Thema: US0390143032
RKDA, US0390143032
stock-5275746_1920.jpg - Foto: THN
Arcadia Biosciences stock heads into Q3 report with estimates in focus
Arcadia Biosciences stock faces a November 5 earnings release before the US open. Investors are watching revenue and another expected loss.
ad-hoc-news.de, heute 03:01 Uhr
RKDA, US0390143032
Arcadia Biosciences files S-8 filing for Arcadia Biosciences ...
The S-8 covers employee plans. Nasdaq's USD 2.50 million equity threshold now shapes Arcadia Biosciences stock.
ad-hoc-news.de, 21.10.26 00:16 Uhr
RKDA, US0390143032
Arcadia Biosciences files S-8 as Nasdaq tests Arcadia Biosciences ...
The September 30 filing registered employee-plan shares. Nasdaq's USD 2.50 million equity test now frames Arcadia Biosciences stock.
ad-hoc-news.de, 16.10.26 01:13 Uhr
RKDA, US0390143032
Arcadia Biosciences stock stays below Nasdaq's USD 1 threshold ...
Arcadia Biosciences stock was last at USD 0.29 on October 5, 2026, down 0.52 percent. Q2 revenue was USD 1.443 million and net loss was USD 6.266 million.
ad-hoc-news.de, 06.10.26 14:58 Uhr
RKDA, US0390143032
Arcadia Biosciences approves reverse split plan affecting ...
Nasdaq requires USD 2.5 million in equity by October 15, 2026, versus USD 633,000. For RKDA stock, equity was USD 633,000 on June 30, 2026.
ad-hoc-news.de, 05.10.26 21:30 Uhr
